X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-04-16 | ACLX | Ware Olivia C | Dir | S - Sale+OE | $55.55 | -9,402 | 0 | -100% | -$522,260 | |||||
2024-04-01 | ACLX | Elghandour Rami | SEE REMARKS | S - Sale | $67.09 | -23,086 | 69,253 | -25% | -$1,548,887 | ||||||
| DM | 2024-03-22 | ACLX | Heery Christopher | CHIEF MEDICAL OFFICER | S - Sale+OE | $70.06 | -46,815 | 8,938 | -84% | -$3,279,714 | |||||
2024-03-21 | ACLX | Carroll Jill | Dir | S - Sale | $70.55 | -504,263 | 1,479,148 | -25% | -$35,575,755 | ||||||
2024-03-18 | ACLX | Gilson Michelle | CFO | S - Sale | $69.34 | -6,825 | 9,485 | -42% | -$473,255 | ||||||
| D | 2024-03-15 | ACLX | Ware Olivia C | Dir | S - Sale+OE | $70.40 | -9,000 | 0 | -100% | -$633,582 | |||||
| M | 2024-02-08 | ACLX | Heery Christopher | CHIEF MEDICAL OFFICER | S - Sale | $63.33 | -10,111 | 30,303 | -25% | -$640,352 | |||||
| M | 2024-02-08 | ACLX | Elghandour Rami | SEE REMARKS | S - Sale | $63.33 | -38,065 | 92,339 | -29% | -$2,410,740 | |||||
2024-01-04 | ACLX | Heery Christopher | Chief Medical Officer | S - Sale | $55.27 | -7,598 | 17,859 | -30% | -$419,926 | ||||||
2024-01-04 | ACLX | Gilson Michelle | CFO | S - Sale | $55.27 | -8,514 | 16,310 | -34% | -$470,551 | ||||||
2024-01-04 | ACLX | Elghandour Rami | See Remarks | S - Sale | $55.27 | -29,073 | 60,193 | -33% | -$1,606,804 | ||||||
| D | 2023-12-18 | ACLX | Heery Christopher | Chief Medical Officer | S - Sale+OE | $50.17 | -120,000 | 7,795 | -94% | -$6,020,281 | |||||
2023-12-14 | ACLX | Carroll Jill | Dir | S - Sale | $49.13 | -504,263 | 1,983,411 | -20% | -$24,774,441 | ||||||
| D | 2023-08-04 | ACLX | Heery Christopher | Chief Medical Officer | S - Sale+OE | $35.38 | -3,000 | 7,795 | -28% | -$106,133 | |||||
| D | 2023-07-03 | ACLX | Heery Christopher | Chief Medical Officer | S - Sale+OE | $31.75 | -3,000 | 7,795 | -28% | -$95,246 | |||||
2023-05-31 | ACLX | Elghandour Rami | See Remarks | S - Sale | $44.27 | -2,600 | 36,169 | -7% | -$115,099 | ||||||
| M | 2023-05-31 | ACLX | Carroll Jill | Dir | S - Sale | $41.71 | -340,720 | 2,487,674 | -12% | -$14,212,623 | |||||
| DM | 2023-05-24 | ACLX | Gilson Michelle | CFO | S - Sale+OE | $42.58 | -14,704 | 9,485 | -61% | -$626,151 | |||||
2023-05-11 | ACLX | Carroll Jill | Dir | S - Sale | $45.01 | -638,417 | 2,828,394 | -18% | -$28,736,223 | ||||||
2023-05-11 | ACLX | Sr One Capital Management, LLC | 10% | S - Sale | $45.01 | -1,012,833 | 4,487,174 | -18% | -$45,589,317 | ||||||
| M | 2023-05-09 | ACLX | Heery Christopher | Chief Medical Officer | S - Sale | $45.15 | -2,697 | 7,795 | -26% | -$121,766 | |||||
2023-05-05 | ACLX | Heery Christopher | Chief Medical Officer | S - Sale | $45.00 | -1,200 | 10,492 | -10% | -$54,002 | ||||||
| D | 2023-05-03 | ACLX | Heery Christopher | Chief Medical Officer | S - Sale+OE | $43.44 | -3,000 | 11,692 | -20% | -$130,329 | |||||
| D | 2023-04-24 | ACLX | Heery Christopher | Chief Medical Officer | S - Sale+OE | $40.00 | -20,000 | 11,692 | -63% | -$800,068 | |||||
| DM | 2023-04-18 | ACLX | Heery Christopher | Chief Medical Officer | S - Sale+OE | $35.01 | -21,642 | 11,692 | -65% | -$757,661 | |||||
| D | 2023-04-03 | ACLX | Heery Christopher | Chief Medical Officer | S - Sale+OE | $30.71 | -3,000 | 15,589 | -16% | -$92,121 | |||||
| D | 2023-02-09 | ACLX | Heery Christopher | Chief Medical Officer | S - Sale+OE | $30.77 | -6,966 | 15,589 | -31% | -$214,333 | |||||
| D | 2023-02-09 | ACLX | Elghandour Rami | See Remarks | S - Sale+OE | $30.77 | -31,442 | 38,769 | -45% | -$967,423 | |||||
| D | 2023-02-03 | ACLX | Heery Christopher | Chief Medical Officer | S - Sale+OE | $35.11 | -1,255 | 0 | -100% | -$44,068 | |||||
| D | 2023-01-03 | ACLX | Heery Christopher | Chief Medical Officer | S - Sale+OE | $31.11 | -2,500 | 0 | -100% | -$77,775 | |||||
2022-12-23 | ACLX | Sandell Scott D | 10% | S - Sale | $31.67 | -390 | 4,746,494 | 0% | -$12,353 | ||||||
2022-12-21 | ACLX | Sandell Scott D | 10% | S - Sale | $30.74 | -179 | 4,746,884 | 0% | -$5,502 | ||||||
2022-12-21 | ACLX | Makhzoumi Mohamad | 10% | S - Sale | $30.74 | -179 | 4,745,545 | 0% | -$5,502 | ||||||
2022-12-21 | ACLX | Florence Anthony A. Jr. | 10% | S - Sale | $30.74 | -179 | 4,745,262 | 0% | -$5,502 | ||||||
2022-12-22 | ACLX | Baskett Forest | 10% | S - Sale | $31.45 | -1,628 | 4,745,262 | 0% | -$51,207 | ||||||
| D | 2022-12-13 | ACLX | Heery Christopher | Chief Medical Officer | S - Sale+OE | $30.03 | -12,500 | 0 | -100% | -$375,320 | |||||
2022-06-21 | ACLX | New Enterprise Associates 15, L.P. | 10% | P - Purchase | $16.00 | +312,500 | 6,745,262 | +5% | +$5,000,000 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |